low-field magnetic resonance imaging platform
Press release

Two experts from Siemens Healthineers nominated for German Future Prize for development of novel low-field magnetic resonance imaging platform

Employees of Siemens Healthineers Dr. Stephan Biber and Dr. David Grodzki, together with Prof. Michael Uder, MD, Head of the Radiological Institute of Uniklinikum Erlangen, Germany, have been nominated for the German Future Prize for the development and clinical application of the novel MRI platform Magnetom Free.
Published on September 13, 2023
Nomination for the German Future Prize

Product Pictures

Siemens Healthineers 2023

Siemens Healthineers AG (listed in Frankfurt, Germany: SHL) pioneers breakthroughs in healthcare. For everyone. Everywhere. As a leading medical technology company headquartered in Erlangen, Germany, Siemens Healthineers and its regional companies are continuously developing their product and service portfolio, with AI-supported applications and digital offerings that play an increasingly important role in the next generation of medical technology. These new applications will enhance the company’s foundation in in-vitro diagnostics, image-guided therapy, in-vivo diagnostics, and innovative cancer care. Siemens Healthineers also provides a range of services and solutions to enhance healthcare providers’ ability to provide high-quality, efficient care. In fiscal 2022, which ended on September 30, 2022, Siemens Healthineers, which has approximately 69,500 employees worldwide, generated revenue of around €21.7 billion and adjusted EBIT of almost €3.7 billion. Further information is available at www.siemens-healthineers.com.